ArticleArthritis research & therapy2020

Investigation of toll-like receptor (TLR) 4 inhibitor TAK-242 as a new potential anti-rheumatoid arthritis drug.

Snigdha Samarpita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.